Acadia Healthcare Valuation
ACHC Stock | USD 29.01 0.25 0.85% |
At this time, the firm appears to be overvalued. Acadia Healthcare shows a prevailing Real Value of $27.64 per share. The current price of the firm is $29.01. Our model approximates the value of Acadia Healthcare from analyzing the firm fundamentals such as return on equity of 0.087, and Profit Margin of 0.08 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Acadia Healthcare's price fluctuation is not too volatile at this time. Calculation of the real value of Acadia Healthcare is based on 3 months time horizon. Increasing Acadia Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Acadia Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Acadia Stock. However, Acadia Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 29.01 | Real 27.64 | Hype 29.01 | Naive 31.95 |
The real value of Acadia Stock, also known as its intrinsic value, is the underlying worth of Acadia Healthcare Company, which is reflected in its stock price. It is based on Acadia Healthcare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Acadia Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Acadia Healthcare helps investors to forecast how Acadia stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Acadia Healthcare more accurately as focusing exclusively on Acadia Healthcare's fundamentals will not take into account other important factors: Acadia Healthcare Total Value Analysis
Acadia Healthcare is presently forecasted to have valuation of 4.72 B with market capitalization of 2.72 B, debt of 2.09 B, and cash on hands of 128.37 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Acadia Healthcare fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
4.72 B | 2.72 B | 2.09 B | 128.37 M |
Acadia Healthcare Investor Information
About 97.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.88. Some equities with similar Price to Book (P/B) outperform the market in the long run. Acadia Healthcare has Price/Earnings To Growth (PEG) ratio of 1.32. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 1st of November 2011. Based on the measurements of operating efficiency obtained from Acadia Healthcare's historical financial statements, Acadia Healthcare is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Acadia Healthcare Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Acadia Healthcare has an asset utilization ratio of 52.95 percent. This indicates that the Company is making $0.53 for each dollar of assets. An increasing asset utilization means that Acadia Healthcare is more efficient with each dollar of assets it utilizes for everyday operations.Acadia Healthcare Ownership Allocation
The majority of Acadia Healthcare outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Acadia Healthcare to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Acadia Healthcare. Please pay attention to any change in the institutional holdings of Acadia Healthcare as this could imply that something significant has changed or is about to change at the company.Acadia Healthcare Profitability Analysis
The company reported the previous year's revenue of 3.15 B. Net Income was 264.48 M with profit before overhead, payroll, taxes, and interest of 1.35 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Acadia Healthcare's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Acadia Healthcare and how it compares across the competition.
About Acadia Healthcare Valuation
The stock valuation mechanism determines Acadia Healthcare's current worth on a weekly basis. Our valuation model uses a comparative analysis of Acadia Healthcare. We calculate exposure to Acadia Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Acadia Healthcare's related companies.Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company was founded in 2005 and is headquartered in Franklin, Tennessee. Acadia Healthcr operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 22500 people.
Acadia Healthcare Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 92.1 M | |
Quarterly Earnings Growth Y O Y | -0.429 | |
Forward Price Earnings | 11.1235 |
Complementary Tools for Acadia Stock analysis
When running Acadia Healthcare's price analysis, check to measure Acadia Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acadia Healthcare is operating at the current time. Most of Acadia Healthcare's value examination focuses on studying past and present price action to predict the probability of Acadia Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acadia Healthcare's price. Additionally, you may evaluate how the addition of Acadia Healthcare to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |